POWERED BY MOMENTUM MEDIA
CSL
Funds management
Australian equity managers are backing biotech CSL despite its falling share price and unsuccessful vaccine trials, stating it is likely to be a recovery beneficiary. ...
Funds management
After announcing it is producing a COVID vaccine, Money Management looks at which funds have the highest allocation to the biotech company....
Superannuation
Government backbenchers have pointed to evidence that AustralianSuper chief executive, Ian Silk, spoke to a critic of the Victorian Government COVID-19 lockdown as eviden...
Funds management
Robeco believes healthcare companies should be subject to stronger ethics and sustainability research with those meeting higher criteria being rewarded with higher valuat...
Funds management
Australian investors are now choosing stocks over property and other investments, according to a survey. ...
Funds management
The current state of market offers great opportunities for contrarian investors with a focus on fundamentals, Allan Gray’s chief investment officer said....
Funds management
Fidelity has identified three sectors that are attractively priced for investors looking to pick up blue-chip stocks at cheap prices following the COVID-19 fallout....
Never miss the latest news and developments in wealth management industry
MARKET INSIGHTS
Podcast
Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...
This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...
Interesting. Would be good to know the details of the StrategyOne deal....